Eventide Asset Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-590,602
| Closed | -$1.1M | – | 149 |
|
|
2022
Q1 | $1.1M | Hold |
590,602
| – | – | 0.02% | 136 |
|
|
2021
Q4 | $1.29M | Hold |
590,602
| – | – | 0.02% | 143 |
|
|
2021
Q3 | $1.97M | Hold |
590,602
| – | – | 0.03% | 150 |
|
|
2021
Q2 | $1.58M | Hold |
590,602
| – | – | 0.02% | 148 |
|
|
2021
Q1 | $1.26M | Sell |
590,602
-288,939
| -33% | -$618K | 0.02% | 152 |
|
|
2020
Q4 | $2.06M | Hold |
879,541
| – | – | 0.03% | 142 |
|
|
2020
Q3 | $1.71M | Hold |
879,541
| – | – | 0.03% | 132 |
|
|
2020
Q2 | $2.47M | Hold |
879,541
| – | – | 0.05% | 122 |
|
|
2020
Q1 | $2.13M | Hold |
879,541
| – | – | 0.07% | 106 |
|
|
2019
Q4 | $4.3M | Buy |
879,541
+487,028
| +124% | +$2.38M | 0.12% | 84 |
|
|
2019
Q3 | $2.29M | Sell |
392,513
-487,028
| -55% | -$2.84M | 0.08% | 93 |
|
|
2019
Q2 | $5.52M | Hold |
879,541
| – | – | 0.17% | 85 |
|
|
2019
Q1 | $5.78M | Hold |
879,541
| – | – | 0.2% | 89 |
|
|
2018
Q4 | $3.48M | Buy |
879,541
+106,985
| +14% | +$423K | 0.15% | 95 |
|
|
2018
Q3 | $8.14M | Buy |
+772,556
| New | +$8.14M | 0.3% | 84 |
|